AS
CBAY

Altshuler Shaham’s Cymabay Therapeutics CBAY Stock Holding History

Altshuler Shaham’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-66,400
Closed -$98K – 609
2020
Q1 		$98K Sell
66,400
-27,429
-29% -$46.1K ﹤0.01% 172
2019
Q4 		$184K Hold
93,829
– – 0.01% 167
2019
Q3 		$474K Buy
93,829
+1,191
+1% +$7.21K 0.02% 90
2019
Q2 		$663K Buy
92,638
+5,063
+6% +$57.3K 0.03% 96
2019
Q1 		$1.16M Hold
87,575
– – 0.05% 81
2018
Q4 		$689K Sell
87,575
-432
-0.5% -$4.11K 0.03% 96
2018
Q3 		$975K Hold
88,007
– – 0.05% 88
2018
Q2 		$1.18M Buy
88,007
+27,600
+46% +$345K 0.1% 78
2018
Q1 		$785K Sell
60,407
-4,393
-7% -$54.6K 0.1% 84
2017
Q4 		$596K Buy
+64,800
New +$554K 0.08% 77

Other funds holding CBAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Altshuler Shaham's CBAY Position: Q2 2020 in Review

Altshuler Shaham sold out of Cymabay Therapeutics (CBAY) in Q2 2020, closing a stake of 66,400 shares — an estimated $98K sold.

Altshuler Shaham first reported a position in CBAY in Q4 2017 and held it in 10 quarters. The position peaked at $1.18M in Q2 2018. 114 funds tracked by Wall St. Rank hold CBAY as of Q2 2020.

  • Altshuler Shaham reported no remaining Cymabay Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Altshuler Shaham sold 66,400 Cymabay Therapeutics shares in Q2 2020, an estimated $98K.
  • Altshuler Shaham first reported a position in Cymabay Therapeutics in Q4 2017 and held it in 10 quarters.
  • Altshuler Shaham's Cymabay Therapeutics position peaked at $1.18M in Q2 2018.
  • 114 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q2 2020.

Based on Altshuler Shaham's 13F filing for Q2 2020, filed 13 Aug 2020.